Nano Drug Delivery for Colon Cancer: Innovations, Challenges, and Applications is a breakthrough exploration that delves into the latest advancements in colon cancer diagnosis and treatment. This comprehensive guide, composed of 11 detailed chapters, focuses on the design, synthesis, and application of various nanodrug delivery systems, showcasing how nanoparticulate drug carriers can significantly enhance therapeutic efficacy through strategic design. Aimed at graduates, clinical researchers, and scientists, this book addresses the complexities and challenges in drug and gene delivery. Beyond its technical insights, the book highlights the global health impact of colon cancer and offers a roadmap for developing more efficient and targeted treatments.
It serves as a vital resource, fostering interdisciplinary knowledge and advancements that have the potential to revolutionize colon cancer therapeutics. The book's interdisciplinary approach ensures it is a beacon of knowledge for those seeking to navigate and innovate within this critical field.
1) Etiology and pathophysiology of colon cancer
2) Current trends of targeted nanoparticulate carriers for the treatment of colon cancer
3) Lipid nanocarrier-based drug delivery for the treatment of colon cancer
4) Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
5) siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Colon Cancer
6) Carbon-Based Quantum Dots and Nanotubes for Colon Cancer Targeting and Drug Delivery
7) Recent trends of extracellular vesicles for therapeutic intervention of Colon Cancer
8)Mitochondria-targeted drug delivery systems for the effective treatment of colon cancer
9) Revolutionizing Colon Cancer Care: Advances in Carbon-Based Materials as theranostic agents
10) Surface modified Metal Nanoparticles in Colon Cancer Therapy
11)Nano-based Phyto drug delivery systems for the management of colon cancer
12) Role of polymeric nanoparticles for the treatment of Colon cancer
13) Nanomicelles based drug delivery systems as for targeted therapy of colon cancer
14) Regulatory framework in the Nanomedicine targeting Colon Cancer
15) Current and future perspectives of nanomedicine in colon cancer treatment
Arun Kumar Singh earned his M. Pharm in Pharmaceutics from Galgotias University and currently serves as an Assistant Professor at the Amity Institute of Pharmacy, Amity University, Greater Noida. With over a decade of experience teaching pharmacology-related courses, Professor Singh has cultivated a diverse range of research interests, including nano-formulation, blockchain, IoT, machine learning, cancer, artificial intelligence, big data, and neuroscience. He has authored 5 book chapters, edited multiple books with notable international publishers, and has published 24 review papers, including two in the prestigious Biochimica et Biophysica Acta (BBA) Reviews on Cancer. Renowned for his research acumen, innovative thinking, leadership, and positive outlook, Professor Singh's dedication and hard work have distinguished him as a leading figure in his field.
Vipan Kumar is working as a Professor (Associate) at Department of Pharmaceutical Chemistry, JCDM College of Pharmacy, Sirsa. Dr. Kumar has more than 10 years of teaching and research experience. He has published dozens of publications in peer-reviewed international and national journal. He has authored 2 books. Dr. Kumar is an editorial and reviewer board member of several scientific journals of intentional repute. He is also serving as a CPCSEA Nominee in various institutes IAEC committees and served in University PGBOS committees.
Dr. Pranav Kumar Prabhakar is currently working as a Professor in the Department of Biotechnology at Nagaland University, Kohima, Nagaland, India. He has been listed among the Worlds Top 2% Scientists (as published by Stanford University, USA, in 2021, 2022, 2023, and 2024). He earned his PhD in Biotechnology from IIT Madras. His primary research interests include elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He also serves as an editorial board member and reviewer for several reputed national and international journals. Dr. Pranav has received various honors, including a travel grant to attend ATTD 2009 in Greece, sponsored by the Indian Institute of Technology Madras and the Council for Scientific and Industrial Research (CSIR), and approved by the Department of Science and Technology (DST). He has published over 115 research articles in journals, authored or edited 17 books, contributed more than 40 book chapters, and delivered 9 oral and poster presentations at scientific meetings. Dr Dhanawat is an Associate Professor at Amity Institute of Pharmacy, Amity University Haryana, Haryana, India. She has 17 years of teaching and research experience. She has attended several national and international conferences in India and abroad the recipient of the travels award in the DDD section of AAPS-2010, National Biotechnology Conference, California, USA, she has also grabbed many other fellowships and awards, she has 65 Publications in her account, Patent 02, Books 6, Book Chapter 09, Book Editor 01, Guest Editor Thematic Issue 01, Copyright 01.
Dr. Neeraj Mishra is a Professor and Head of the Department of Pharmaceutics at Amity Institute of Pharmacy, India, a position he has held since July 2019. With nearly two decades of teaching and research experience, Dr. Mishra has authored over 100 publications on novel drug delivery systems, focusing on nanocarriers and microparticles for treating breast and colon cancer, as well as neurodegenerative disorders. He has written several books and book chapters, and holds three international and two Indian patents. Dr. Mishra has received numerous accolades, including the "Distinguished Professor Award" (2019, 2021) and the "Outstanding Scientist Award" (2020). He has served as a guest editor for Bentham Sciences and is recognized in Stanford University's World Scientists Rankings for 2022 and 2024.
